Ilex Medical Market Cap ($140.14 Million)
Market Cap & Net Worth: Ilex Medical (ILX)
Ilex Medical market cap. Ilex Medical (TA:ILX) has a market capitalization of $140.14 Million (ILA52.27 Billion) as of November 1, 2026. Listed on the TA stock exchange, this Israel-based company holds position #17724 globally and #223 in its home market, demonstrating a 7.60% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ilex Medical's stock price ILA4672.00 by its total outstanding shares 11188107 (11.19 Million). Also see Ilex Medical (ILX) cash conversion ratio for how efficiently the company converts equity into cash flow.
Ilex Medical Market Cap History (2015–2026)
Ilex Medical market cap history from 2015 to 2026. Data shows growth from $80.69 Million to $140.14 Million (4.86% CAGR). Check ILX share price today for real-time trading data and today's change.
Ilex Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ilex Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Ilex Medical annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.21x
Ilex Medical's market cap is 0.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.59x
Ilex Medical's market cap is 3.59 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $99.24 Million | $518.94 Million | $27.65 Million | 0.19x | 3.59x |
| 2017 | $130.35 Million | $553.66 Million | $37.40 Million | 0.24x | 3.48x |
| 2018 | $132.47 Million | $601.13 Million | $46.98 Million | 0.22x | 2.82x |
| 2019 | $218.90 Million | $633.96 Million | $60.26 Million | 0.35x | 3.63x |
| 2020 | $323.22 Million | $946.45 Million | $120.62 Million | 0.34x | 2.68x |
| 2021 | $449.92 Million | $1.06 Billion | $197.48 Million | 0.42x | 2.28x |
| 2022 | $274.98 Million | $872.54 Million | $102.12 Million | 0.32x | 2.69x |
| 2023 | $172.73 Million | $930.89 Million | $50.88 Million | 0.19x | 3.39x |
| 2024 | $224.66 Million | $920.37 Million | $38.98 Million | 0.24x | 5.76x |
| 2025 | $199.47 Million | $930.83 Million | $55.55 Million | 0.21x | 3.59x |
Competitor Companies of ILX by Market Capitalization
Companies near Ilex Medical in the global market cap rankings as of November 1, 2026. Also see Ilex Medical (ILX) total assets for a full breakdown of the balance sheet.
Key companies related to Ilex Medical by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #248 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #451 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #626 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.30 Billion USD ( AU$31.51 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #248 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $994.58 |
| #451 | Cencora Inc. | NYSE:COR | $61.32 Billion | $330.84 |
| #626 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $250.48 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.30 Billion | AU$2.73 |
Market Capitalization of Ilex Medical (2015–2026)
Market capitalization of Ilex Medical from 2015 to today. Between 2015 and today, Ilex Medical's market cap moved from $80.69 Million to $ 140.14 Million, with a yearly change of 4.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA140.14 Million | -29.74% |
| 2025 | ILA199.47 Million | -11.21% |
| 2024 | ILA224.66 Million | +30.06% |
| 2023 | ILA172.73 Million | -37.18% |
| 2022 | ILA274.98 Million | -38.88% |
| 2021 | ILA449.92 Million | +39.20% |
| 2020 | ILA323.22 Million | +47.66% |
| 2019 | ILA218.90 Million | +65.24% |
| 2018 | ILA132.47 Million | +1.63% |
| 2017 | ILA130.35 Million | +31.34% |
| 2016 | ILA99.24 Million | +22.99% |
| 2015 | ILA80.69 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Ilex Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $140.14 Million USD |
| MoneyControl | $140.14 Million USD |
| MarketWatch | $140.14 Million USD |
| marketcap.company | $140.14 Million USD |
| Reuters | $140.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ilex Medical
Ilex Medical Ltd engages in the import, marketing, distribution and sale of medical laboratory equipment and various diagnostic products, diagnostic systems, and kits and consumables in Israel, the United States, and internationally. The company also provides laboratory services, as well as is involved in the development, production, marketing and sale of software systems for information manageme… Read more